Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients - Trial NCT06228170
Access comprehensive clinical trial information for NCT06228170 through Pure Global AI's free database. This phase not specified trial is sponsored by Zeng Changhao and is currently Withdrawn. The study focuses on Traumatic Brain Injury. Target enrollment is 0 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zeng Changhao
People's Hospital of Zhengzhou University
Timeline & Enrollment
N/A
Jan 30, 2024
May 30, 2024
Primary Outcome
Penetration-Aspiration Scale
Summary
The goal of this or clinical trial is to explore efficacy of stellate ganglion block on
 dysphagia and activities of daily living in Traumatic Brain Injury Patients. The main
 question it aims to answer are:
 
 Can stellate ganglion block improve the dysphagia and activities of daily living in Traumatic
 Brain Injury Patients.
 
 Traumatic Brain Injury Patients will be divided into the the control group and observation
 group evenly. All the patients were provided with routine therapy, while the patients in the
 observation group were given stellate ganglion block. The swallowing function, and activities
 of daily living of the two groups of patients before and after treatment were evaluated.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06228170
Non-Device Trial